MGP Ingredients, Inc. Investors: February 14, 2025 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
MGP Ingredients (MGPI) faces a securities class action lawsuit for allegedly making false statements about its business and product demand between May 4, 2023, and October 30, 2024. The lawsuit claims MGPI executives misled investors about inventory issues and product demand strength.
The company's stock experienced significant drops following three key revelations: On February 22, 2024, MGPI's stock fell nearly 15% after announcing below-consensus 2024 revenue guidance and acknowledging industry-wide inventory destocking issues. On October 17, 2024, the stock declined approximately 30% after disclosing soft demand and high inventory problems. Finally, on October 31, 2024, shares dropped another 15% following announcements of whiskey production scaling down and inventory challenges.
MGP Ingredients (MGPI) è coinvolta in una causa legale collettiva per titoli per presunti dichiarazioni false riguardo al proprio business e alla domanda di prodotto tra il 4 maggio 2023 e il 30 ottobre 2024. La causa afferma che i dirigenti di MGPI hanno fuorviato gli investitori riguardo a problemi di inventario e alla forza della domanda di prodotto.
Le azioni della società hanno subito significative flessioni dopo tre rivelazioni chiave: il 22 febbraio 2024, le azioni di MGPI sono scese di quasi il 15% dopo aver annunciato previsioni di fatturato per il 2024 inferiori alle attese e aver riconosciuto problemi di disinventario a livello di settore. Il 17 ottobre 2024, il titolo è diminuito di circa il 30% dopo aver rivelato una domanda debole e problemi di inventario elevati. Infine, il 31 ottobre 2024, le azioni sono ulteriormente scese del 15% dopo gli annunci di riduzione della produzione di whisky e delle sfide legate all'inventario.
MGP Ingredients (MGPI) enfrenta una demanda colectiva de valores por presuntamente hacer declaraciones falsas sobre su negocio y la demanda de productos entre el 4 de mayo de 2023 y el 30 de octubre de 2024. La demanda afirma que los ejecutivos de MGPI engañaron a los inversores sobre problemas de inventario y la fortaleza de la demanda de productos.
Las acciones de la compañía experimentaron caídas significativas tras tres revelaciones clave: el 22 de febrero de 2024, las acciones de MGPI cayeron casi un 15% después de anunciar proyecciones de ingresos para 2024 por debajo de las expectativas y reconocer problemas de desabastecimiento en toda la industria. El 17 de octubre de 2024, las acciones disminuyeron aproximadamente un 30% tras revelar una demanda débil y problemas de inventario elevados. Finalmente, el 31 de octubre de 2024, las acciones cayeron otro 15% tras anuncios de reducción en la producción de whisky y dificultades con el inventario.
MGP Ingredients (MGPI)는 2023년 5월 4일에서 2024년 10월 30일 사이에 비즈니스와 제품 수요에 대해 허위 진술을 했다는 혐의로 증권 집단 소송에 직면해 있습니다. 소송은 MGPI 경영진이 재고 문제와 제품 수요 강도에 대해 투자자들을 오도했다는 주장을 하고 있습니다.
회사의 주가는 세 가지 주요 폭로 이후 큰 폭으로 하락했습니다: 2024년 2월 22일, MGPI의 주가는 2024년 매출 전망이 전문가 예상치보다 낮고 업계 전반의 재고 감소 문제를 인정한 후 거의 15% 하락했습니다. 2024년 10월 17일, 주가는 부진한 수요와 높은 재고 문제를 공개한 후 약 30% 하락했습니다. 마지막으로, 2024년 10월 31일에는 위스키 생산 축소와 재고 문제의 발표 이후 주가가 다시 15% 하락했습니다.
MGP Ingredients (MGPI) fait face à une action collective en valeurs mobilières pour avoir prétendument fait de fausses déclarations concernant son activité et la demande de produits entre le 4 mai 2023 et le 30 octobre 2024. Le procès affirme que les dirigeants de MGPI ont induit en erreur les investisseurs sur les problèmes d'inventaire et la force de la demande de produits.
Les actions de l'entreprise ont connu des baisses significatives après trois révélations clés : le 22 février 2024, l'action de MGPI a chuté de près de 15 % après l'annonce de prévisions de chiffre d'affaires pour 2024 inférieures aux attentes et la reconnaissance de problèmes de désapprovisionnement dans l'industrie. Le 17 octobre 2024, l'action a diminué d'environ 30 % après avoir dévoilé une demande faible et des problèmes d'inventaire élevés. Enfin, le 31 octobre 2024, les actions ont encore chuté de 15 % après les annonces de réduction de la production de whisky et des défis liés à l'inventaire.
MGP Ingredients (MGPI) sieht sich einer Sammelklage wegen Wertpapieren gegenüber, da behauptet wird, dass falsche Aussagen über das Unternehmen und die Produktnachfrage zwischen dem 4. Mai 2023 und dem 30. Oktober 2024 gemacht wurden. Die Klage behauptet, dass die MGPI-Führungskräfte die Investoren über Lagerbestandsprobleme und die Stärke der Produktnachfrage irreführten.
Die Aktien des Unternehmens erlebten nach drei wichtigen Enthüllungen erhebliche Rückgänge: Am 22. Februar 2024 fiel die MGPI-Aktie um fast 15%, nachdem das Unternehmen die Umsatzprognose für 2024 unter dem Marktkonsens bekannt gegeben hatte und Probleme mit der Lagerbestandsverringerung in der Branche anerkannt hatte. Am 17. Oktober 2024 fiel die Aktie um etwa 30%, nachdem schwache Nachfrage und hohe Lagerbestandsprobleme offengelegt worden waren. Schließlich fiel am 31. Oktober 2024 der Kurs erneut um 15%, nachdem die Reduzierung der Whiskyproduktion und Herausforderungen im Lagerbestand bekannt gegeben wurden.
- None.
- Below-consensus revenue guidance for 2024
- Significant inventory destocking issues affecting sales
- Soft product demand leading to reduced whiskey production
- Stock price declined 15% on February 22, 2024 ($13.65 drop)
- Stock price fell 30% over three days in October 2024 ($24.07 drop)
- Additional 15% stock price decline on October 31, 2024 ($8.27 drop)
Insights
Class Period: May 4, 2023 – October 30, 2024
Lead Plaintiff Motion Deadline: February 14, 2025
Case information: https://lieffcabraser.com/securities/mgpi/
Contact us: Email or text investorinfo@lchb.com or call 1-800-541-7358
MGPI, incorporated and headquartered in
The action alleges that, throughout the Class Period, MGPI and certain of its senior executives made materially false and misleading statements regarding the Company’s business and demand for its liquor products. Specifically, Defendants falsely and repeatedly assured investors that the Company was not facing excess inventory issues and demand for its products remained strong.
On February 22, 2024, the truth began to emerge. The Company issued full-year 2024 revenue guidance that was below industry consensus and noted that “inventory destocking at a wholesale level will remain an issue for the branded spirits industry in 2024.” The Company’s new CEO and President assured that the Company had worked hard to manage wholesale inventory levels and that demand for its products remained healthy. Following this news, MGPI’s common stock price fell by
On October 17, 2024, MGPI revealed that soft demand and high inventories were in fact undermining its sales. On this news, MGPI’s stock price declined by
Finally, on October 31, 2024, the Company stated that it would have to “scale down our whiskey production” and that “further inventory tightening is a headwind in the near term.” On this news, MGPI’s stock price declined by another
About Lieff Cabraser
Lieff Cabraser Heimann & Bernstein, LLP, with over 125 attorneys in offices in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241223318163/en/
Source/Contact
Sharon Lee
Lieff Cabraser Heimann & Bernstein, LLP
415 956-1000
slee@lchb.com
Source: Lieff Cabraser Heimann & Bernstein, LLP
FAQ
What caused MGPI stock to drop 30% in October 2024?
What is the deadline for the MGPI securities class action lawsuit?
What period does the MGPI class action lawsuit cover?
How much did MGPI stock fall after the February 22, 2024 announcement?